| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070566 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
Coding region mutation in TP53 occurs in 25% of ACCs with a trend toward a poorer prognosis. Promoter methylation of TP53 is not present in ACC as a mechanism for tumour suppressor gene (TSG) inactivation and, therefore, other genes in the 17p13 region are implicated in adrenal carcinogenesis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Sidhu, E. Martin, C. Gicquel, J. Melki, S.J. Clark, P. Campbell, C.J. Magarey, K.M. Schulte, H.D. Röher, L. Delbridge, B.G. Robinson,